Longitudinal profiling of the microbiome at four body sites reveals core stability and individualized dynamics during health and diseaseOriginal paper
Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.
Read MoreWhat was studied?
This study examined the microbial composition and temporal dynamics of the human microbiome at four body sites: stool, oral, skin, and nasal. The researchers tracked how these microbial communities changed over time and how they related to host multi-omics data, immune markers, and clinical features. The goal was to understand how the microbiome behaves dynamically during both health and disease.
Who was studied?
The study followed 86 participants over a period of 6 years, sampling microbiomes from four body sites in each person. The abstract does not specify additional demographic details such as age range or sex distribution. Some participants in the cohort were insulin-resistant, allowing comparison between metabolically healthy and metabolically disrupted individuals.
What were the most important findings?
Microbiome stability and individuality were found to be body-site specific and strongly shaped by the host, with the stool and oral microbiomes proving more stable than the skin and nasal microbiomes, likely due to differing levels of interaction with the host and external environment. The researchers identified both individual-specific and commonly shared bacterial taxa, and individualized taxa showed greater stability over time. Notably, microbiome dynamics were correlated across different body sites, pointing to systemic patterns driven by host-microbial-environment interactions. Insulin-resistant individuals showed altered microbial stability and disrupted associations among microbiome composition, molecular markers, and clinical features.
What are the greatest implications of this study?
The findings suggest that microbiome stability is not uniform across the body and that host factors play a central role in shaping which microbial communities remain stable versus dynamic over time. The correlation of microbiome dynamics across separate body sites implies a systemic, whole-body relationship between host and microbiota rather than site-isolated behavior. The disrupted microbiome-host associations seen in insulin resistance suggest that metabolic disease may involve a breakdown in normal host-microbial coupling, offering a potential angle for understanding or monitoring metabolic disease through longitudinal microbiome tracking.